Literature DB >> 8781322

Ultrasonographic determination of ascitic volume.

J Inadomi1, J P Cello, J Koch.   

Abstract

The purpose of this study was to develop a method by which ascitic volume can be calculated using transcorporeal ultrasonography, and to determine the accuracy of this method by comparison with the volume of distribution of a radiolabeled tracer (indicator dilution technique [IDT]). Subjects with ascites confirmed by ultrasonography were recruited from the San Francisco General Hospital Gastroenterology and Liver Clinics. With subjects in the prone position on their hands and knees, ultrasonographic measurements were obtained along the ventral surface of the abdomen. The greatest vertical depth of ascitic fluid was recorded, and the abdominal circumference was measured from this point. The ascitic fluid volume was modeled as a segment of a sphere. IDT was performed as the reference method by injecting 99mTc-labeled macroalbumin into the peritoneal cavity and determining the volume of distribution of the indicator. Nine patients were evaluated. The median volume of ascites measured by the IDT was 11.2 L (range, 1.5-17.0 L). The median volume calculated by the ultrasonographic method was 10.3 L (range, 1.2-18.0 L). The correlation coefficient between the ultrasonographic and IDT was 0.96 (P < .001). Our technique accurately determines the volume of ascites using simple ultrasonographic measurements.

Entities:  

Mesh:

Year:  1996        PMID: 8781322     DOI: 10.1002/hep.510240314

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  9 in total

1.  Recommendations on the Use of Ultrasound Guidance for Adult Abdominal Paracentesis: A Position Statement of the Society of Hospital Medicine.

Authors:  Joel Cho; Trevor P Jensen; Kreegan Reierson; Benji K Mathews; Anjali Bhagra; Ricardo Franco-Sadud; Loretta Grikis; Michael Mader; Ria Dancel; Brian P Lucas; Nilam J Soni
Journal:  J Hosp Med       Date:  2019-01-02       Impact factor: 2.960

Review 2.  Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

Authors:  Emma Kipps; David S P Tan; Stan B Kaye
Journal:  Nat Rev Cancer       Date:  2013-02-21       Impact factor: 60.716

Review 3.  Evaluation and treatment of malignant ascites secondary to gastric cancer.

Authors:  Hiromichi Maeda; Michiya Kobayashi; Junichi Sakamoto
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

4.  Palliative treatment of malignant ascites: profile of catumaxomab.

Authors:  Lila Ammouri; Eric E Prommer
Journal:  Biologics       Date:  2010-05-25

Review 5.  Management of ascites.

Authors:  Fedja A Rochling; Rowen K Zetterman
Journal:  Drugs       Date:  2009       Impact factor: 9.546

6.  Multivariate comparison of B-ultrasound guided and laparoscopic continuous circulatory hyperthermic intraperitoneal perfusion chemotherapy for malignant ascites.

Authors:  Ming-Chen Ba; Hui Long; Shu-Zhong Cui; Yun-Qiang Tang; Yin-Bing Wu; Xiang-Liang Zhang; Hong-Sheng Tang; Sai-Xi Bai
Journal:  Surg Endosc       Date:  2013-02-08       Impact factor: 4.584

7.  Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus.

Authors:  Baochi Liu; Mingrong Cheng; Lin Lang; Lei Li; Yanhui Si; Guangmian Wang
Journal:  Front Physiol       Date:  2021-11-18       Impact factor: 4.566

8.  Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response.

Authors:  Yalei Zhang; Ling Qian; Kun Chen; Sijia Gu; Jia Wang; Zhiqiang Meng; Ye Li; Peng Wang
Journal:  Mol Ther Oncolytics       Date:  2022-03-15       Impact factor: 7.200

9.  Ascites Index - an attempt to objectify the assessment of ascites.

Authors:  Piotr Szkodziak; Piotr Czuczwar; Krzysztof Pyra; Filip Szkodziak; Tomasz Paszkowski; Hugo Rio Tinto; Sławomir Woźniak
Journal:  J Ultrason       Date:  2018
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.